Immunohistochemical expression and localization of somatostatin receptor subtypes in androgen ablated prostate cancer

Roberta Mazzucchelli, Doriana Morichetti, Alfredo Santinelli, Marina Scarpelli, Aldo V. Bono, Antonio Lopez-Beltran, Liang Cheng, Rodolfo Montironi

Research output: Contribution to journalArticle

7 Citations (Scopus)

Abstract

Objective The aim was to examine the expression and localization of the five somatostatin receptors (termed SSTR1 to 5) in radical prostatectomies (RPs) from patients with prostatic adenocarcinoma (PCa) under complete androgen ablation (CAA) before operation. Material The five SSTRs were evaluated in the epithelial, smooth muscle and endothelial cells of normal-looking epithelium (Nep), high-grade prostatic intraepithelial neoplasia (HGPIN) and PCa in 20 RPs with clinically detected PCa from patients under CAA. Twenty RPs with clinically detected PCa from hormonally untreated patients were used as control group. Results Concerning the secretory cells (i) Membrane staining was seen for SSTR3 and SSTR4; the mean percentages of positive cells, higher in SSTR3 than in SSTR4, decreased sharply in HGPIN and PCa compared with Nep; the mean percentages in the androgen ablated group were 30%to 90%lower than in the untreated; (ii) Cytoplasmic staining was seen for all five SSTRs; the mean percentages of positive cells in Nep, HGPIN and PCa of the untreated group were similar, and in general as high as 80% or more; in the treated group, the Nep values were similar to those in the untreated, whereas the values in HGPIN and PCa were lower for SSTR1, three and five, with a decrease of 30% for SSTR1; (iii) Nuclear staining was seen with SSTR4 and SSTR5, the mean percentages for the former being much lower than for the latter; treatment affected both HGPIN and PCa, whose proportions of stained cells were 30% to 55% lower than in the untreated group. Cytoplasmic staining in the basal cells was seen for all five SSTRs, both in Nep and HGPIN. The values in the treated group were lower than in the other, the difference between the two group being in general comprised between 10% and 40%. Treatment did not affect SSTR staining in the smooth muscle and endothelial cells. Conclusions The present study expands our knowledge on the expression and localization of the five SSTRs in the prostate following CAA.

Original languageEnglish
Pages (from-to)235-243
Number of pages9
JournalCellular Oncology
Volume34
Issue number3
DOIs
StatePublished - Jun 2011

Fingerprint

Somatostatin Receptors
Prostatic Intraepithelial Neoplasia
Androgens
Prostatic Neoplasms
Adenocarcinoma
Epithelium
Staining and Labeling
Prostatectomy
Smooth Muscle Myocytes
Endothelial Cells
Prostate
Cell Membrane
Control Groups
Therapeutics

Keywords

  • Complete androgen ablation
  • Highgrade prostatic intraepithelial neoplasia
  • Prostate cancer
  • Somatostatin receptors

ASJC Scopus subject areas

  • Cancer Research
  • Molecular Medicine
  • Oncology
  • Medicine(all)

Cite this

Mazzucchelli, R., Morichetti, D., Santinelli, A., Scarpelli, M., Bono, A. V., Lopez-Beltran, A., ... Montironi, R. (2011). Immunohistochemical expression and localization of somatostatin receptor subtypes in androgen ablated prostate cancer. Cellular Oncology, 34(3), 235-243. https://doi.org/10.1007/s13402-011-0031-y

Immunohistochemical expression and localization of somatostatin receptor subtypes in androgen ablated prostate cancer. / Mazzucchelli, Roberta; Morichetti, Doriana; Santinelli, Alfredo; Scarpelli, Marina; Bono, Aldo V.; Lopez-Beltran, Antonio; Cheng, Liang; Montironi, Rodolfo.

In: Cellular Oncology, Vol. 34, No. 3, 06.2011, p. 235-243.

Research output: Contribution to journalArticle

Mazzucchelli, R, Morichetti, D, Santinelli, A, Scarpelli, M, Bono, AV, Lopez-Beltran, A, Cheng, L & Montironi, R 2011, 'Immunohistochemical expression and localization of somatostatin receptor subtypes in androgen ablated prostate cancer', Cellular Oncology, vol. 34, no. 3, pp. 235-243. https://doi.org/10.1007/s13402-011-0031-y
Mazzucchelli R, Morichetti D, Santinelli A, Scarpelli M, Bono AV, Lopez-Beltran A et al. Immunohistochemical expression and localization of somatostatin receptor subtypes in androgen ablated prostate cancer. Cellular Oncology. 2011 Jun;34(3):235-243. https://doi.org/10.1007/s13402-011-0031-y
Mazzucchelli, Roberta ; Morichetti, Doriana ; Santinelli, Alfredo ; Scarpelli, Marina ; Bono, Aldo V. ; Lopez-Beltran, Antonio ; Cheng, Liang ; Montironi, Rodolfo. / Immunohistochemical expression and localization of somatostatin receptor subtypes in androgen ablated prostate cancer. In: Cellular Oncology. 2011 ; Vol. 34, No. 3. pp. 235-243.
@article{4e3ea4524e764aeb962479e15819859e,
title = "Immunohistochemical expression and localization of somatostatin receptor subtypes in androgen ablated prostate cancer",
abstract = "Objective The aim was to examine the expression and localization of the five somatostatin receptors (termed SSTR1 to 5) in radical prostatectomies (RPs) from patients with prostatic adenocarcinoma (PCa) under complete androgen ablation (CAA) before operation. Material The five SSTRs were evaluated in the epithelial, smooth muscle and endothelial cells of normal-looking epithelium (Nep), high-grade prostatic intraepithelial neoplasia (HGPIN) and PCa in 20 RPs with clinically detected PCa from patients under CAA. Twenty RPs with clinically detected PCa from hormonally untreated patients were used as control group. Results Concerning the secretory cells (i) Membrane staining was seen for SSTR3 and SSTR4; the mean percentages of positive cells, higher in SSTR3 than in SSTR4, decreased sharply in HGPIN and PCa compared with Nep; the mean percentages in the androgen ablated group were 30{\%}to 90{\%}lower than in the untreated; (ii) Cytoplasmic staining was seen for all five SSTRs; the mean percentages of positive cells in Nep, HGPIN and PCa of the untreated group were similar, and in general as high as 80{\%} or more; in the treated group, the Nep values were similar to those in the untreated, whereas the values in HGPIN and PCa were lower for SSTR1, three and five, with a decrease of 30{\%} for SSTR1; (iii) Nuclear staining was seen with SSTR4 and SSTR5, the mean percentages for the former being much lower than for the latter; treatment affected both HGPIN and PCa, whose proportions of stained cells were 30{\%} to 55{\%} lower than in the untreated group. Cytoplasmic staining in the basal cells was seen for all five SSTRs, both in Nep and HGPIN. The values in the treated group were lower than in the other, the difference between the two group being in general comprised between 10{\%} and 40{\%}. Treatment did not affect SSTR staining in the smooth muscle and endothelial cells. Conclusions The present study expands our knowledge on the expression and localization of the five SSTRs in the prostate following CAA.",
keywords = "Complete androgen ablation, Highgrade prostatic intraepithelial neoplasia, Prostate cancer, Somatostatin receptors",
author = "Roberta Mazzucchelli and Doriana Morichetti and Alfredo Santinelli and Marina Scarpelli and Bono, {Aldo V.} and Antonio Lopez-Beltran and Liang Cheng and Rodolfo Montironi",
year = "2011",
month = "6",
doi = "10.1007/s13402-011-0031-y",
language = "English",
volume = "34",
pages = "235--243",
journal = "Cellular oncology (Dordrecht)",
issn = "2211-3428",
publisher = "Springer Netherlands",
number = "3",

}

TY - JOUR

T1 - Immunohistochemical expression and localization of somatostatin receptor subtypes in androgen ablated prostate cancer

AU - Mazzucchelli, Roberta

AU - Morichetti, Doriana

AU - Santinelli, Alfredo

AU - Scarpelli, Marina

AU - Bono, Aldo V.

AU - Lopez-Beltran, Antonio

AU - Cheng, Liang

AU - Montironi, Rodolfo

PY - 2011/6

Y1 - 2011/6

N2 - Objective The aim was to examine the expression and localization of the five somatostatin receptors (termed SSTR1 to 5) in radical prostatectomies (RPs) from patients with prostatic adenocarcinoma (PCa) under complete androgen ablation (CAA) before operation. Material The five SSTRs were evaluated in the epithelial, smooth muscle and endothelial cells of normal-looking epithelium (Nep), high-grade prostatic intraepithelial neoplasia (HGPIN) and PCa in 20 RPs with clinically detected PCa from patients under CAA. Twenty RPs with clinically detected PCa from hormonally untreated patients were used as control group. Results Concerning the secretory cells (i) Membrane staining was seen for SSTR3 and SSTR4; the mean percentages of positive cells, higher in SSTR3 than in SSTR4, decreased sharply in HGPIN and PCa compared with Nep; the mean percentages in the androgen ablated group were 30%to 90%lower than in the untreated; (ii) Cytoplasmic staining was seen for all five SSTRs; the mean percentages of positive cells in Nep, HGPIN and PCa of the untreated group were similar, and in general as high as 80% or more; in the treated group, the Nep values were similar to those in the untreated, whereas the values in HGPIN and PCa were lower for SSTR1, three and five, with a decrease of 30% for SSTR1; (iii) Nuclear staining was seen with SSTR4 and SSTR5, the mean percentages for the former being much lower than for the latter; treatment affected both HGPIN and PCa, whose proportions of stained cells were 30% to 55% lower than in the untreated group. Cytoplasmic staining in the basal cells was seen for all five SSTRs, both in Nep and HGPIN. The values in the treated group were lower than in the other, the difference between the two group being in general comprised between 10% and 40%. Treatment did not affect SSTR staining in the smooth muscle and endothelial cells. Conclusions The present study expands our knowledge on the expression and localization of the five SSTRs in the prostate following CAA.

AB - Objective The aim was to examine the expression and localization of the five somatostatin receptors (termed SSTR1 to 5) in radical prostatectomies (RPs) from patients with prostatic adenocarcinoma (PCa) under complete androgen ablation (CAA) before operation. Material The five SSTRs were evaluated in the epithelial, smooth muscle and endothelial cells of normal-looking epithelium (Nep), high-grade prostatic intraepithelial neoplasia (HGPIN) and PCa in 20 RPs with clinically detected PCa from patients under CAA. Twenty RPs with clinically detected PCa from hormonally untreated patients were used as control group. Results Concerning the secretory cells (i) Membrane staining was seen for SSTR3 and SSTR4; the mean percentages of positive cells, higher in SSTR3 than in SSTR4, decreased sharply in HGPIN and PCa compared with Nep; the mean percentages in the androgen ablated group were 30%to 90%lower than in the untreated; (ii) Cytoplasmic staining was seen for all five SSTRs; the mean percentages of positive cells in Nep, HGPIN and PCa of the untreated group were similar, and in general as high as 80% or more; in the treated group, the Nep values were similar to those in the untreated, whereas the values in HGPIN and PCa were lower for SSTR1, three and five, with a decrease of 30% for SSTR1; (iii) Nuclear staining was seen with SSTR4 and SSTR5, the mean percentages for the former being much lower than for the latter; treatment affected both HGPIN and PCa, whose proportions of stained cells were 30% to 55% lower than in the untreated group. Cytoplasmic staining in the basal cells was seen for all five SSTRs, both in Nep and HGPIN. The values in the treated group were lower than in the other, the difference between the two group being in general comprised between 10% and 40%. Treatment did not affect SSTR staining in the smooth muscle and endothelial cells. Conclusions The present study expands our knowledge on the expression and localization of the five SSTRs in the prostate following CAA.

KW - Complete androgen ablation

KW - Highgrade prostatic intraepithelial neoplasia

KW - Prostate cancer

KW - Somatostatin receptors

UR - http://www.scopus.com/inward/record.url?scp=84555195682&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84555195682&partnerID=8YFLogxK

U2 - 10.1007/s13402-011-0031-y

DO - 10.1007/s13402-011-0031-y

M3 - Article

VL - 34

SP - 235

EP - 243

JO - Cellular oncology (Dordrecht)

JF - Cellular oncology (Dordrecht)

SN - 2211-3428

IS - 3

ER -